Estée Lauder Companies secures minority stake in 111SKIN

Financial details of the transaction were not revealed.

USA – The Estée Lauder Companies Inc. has made a strategic minority investment in 111SKIN, an American luxury clinical skincare line created by acclaimed plastic and reconstructive surgeon Dr. Yannis Alexandrides. 

This move supports the company’s Beauty Reimagined strategy, focusing on consumer-driven innovation in a skincare market influenced by procedures, longevity trends, and demands for visible, treatment-like outcomes. 

111SKIN, launched in 2012, draws from Dr. Alexandrides’ work to hasten post-procedure recovery, featuring its core NAC Y2™ complex that promotes skin restoration and a vibrant, durable glow.

The brand offers more than 30 items, led by the Black Diamond and Reparative lines, priced from USD 50 to USD 1,000. 

Products reach customers through upscale retailers like Harrods, Bluemercury, and Nordstrom, as well as premium spas such as Mandarin Oriental and Aman, alongside e-commerce and direct sales, which account for about 20% of revenue.

Stéphane de La Faverie, President and CEO of The Estée Lauder Companies, noted that skincare is evolving amid overlaps between treatments, wellness, and aesthetics, where shoppers want effective, clinic-derived solutions. 

He praised 111SKIN for channelling Dr. Alexandrides’ over 35 years of surgical and aesthetic experience into potent, luxury formulas backed by clinical knowledge, advanced ingredients, and demonstrated results, positioning it for broader international expansion while retaining its unique appeal.

According to the agreement, Dr. Alexandrides will stay deeply engaged, guiding the brand with its seasoned leadership.

111SKIN thrives in the expanding clinical skincare niche, where medical know-how meets high-powered blends to meet rising consumer expectations. 

North America accounts for roughly 40% of its 2025 revenue, complemented by strongholds in China, the UK, Europe, and Asia Pacific.

The partnership reinforces The Estée Lauder Companies’ push into science-based innovations, mirroring shifts toward more effective, proactive skincare routines.

The Estée Lauder Companies Inc. is a top global player in the production, marketing, and distribution of premium skincare, cosmetics, fragrances, and haircare products, championing prestige and luxury labels. 

Its offerings span about 150 countries under icons like Estée Lauder, Clinique, La Mer, M·A·C, Jo Malone London, TOM FORD, Dr.Jart+, and others including The Ordinary and BALMAIN Beauty.

This move cmes after Estée Lauder Companies (ELC) and Puig confirmed that they are in preliminary discussions about a potential business combination that could create a USD 40 billion beauty powerhouse.

This move is set to reshape the global industry through enhanced scale in skincare, makeup, and especially fragrances. 

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.

Newer Post

Thumbnail for Estée Lauder Companies secures minority stake in 111SKIN

HUL delivers 7% sales growth in  Q4 FY26 following premiumization and volume gains

Older Post

Thumbnail for Estée Lauder Companies secures minority stake in 111SKIN

Viva Matic and LG Electronics partner to revolutionize laundry care in Nigeria